Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 3, 1986 - Issue 2
Submit an article Journal homepage
27
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Pharmacokinetics of Methotrexate and 7-Hydroxy-Methotrexate after High-Dose (33.6 g/m2) Methotrexate Therapy

Lars Slørdal Department of Pharmacology, Institute of Medical Biology; Department of Pediatrics, Institute of Clinical Medicine, University of Tromsø, N-9000, Tromsø, Norway
,
Svein Kolmannskog Department of Pharmacology, Institute of Medical Biology; Department of Pediatrics, Institute of Clinical Medicine, University of Tromsø, N-9000, Tromsø, Norway
,
Per S. Prytz Department of Pharmacology, Institute of Medical Biology; Department of Pediatrics, Institute of Clinical Medicine, University of Tromsø, N-9000, Tromsø, Norway
,
Peter Johan Moe Department of Pediatrics, University of Trondheim, N-7000, Trondheim, Norway
&
Jarle Aarbakke Department of Pharmacology, Institute of Medical Biology, University of Tromsø, N-9000, Tromsø, Norway
Pages 127-134 | Received 17 Dec 1985, Accepted 13 Feb 1986, Published online: 09 Jul 2009

References

  • Jolivet J, Cowan K H, Curt G A. The pharmacology and clinical use of methotrexate. N Engl J Med 1983; 309: 1094–1104
  • Evans W E, Hutson P R, Stewart C F. Methotrexate cerebrospinal fluid and serum concentrations after intermediate dose methotrexate infusion. Clin Pharmacol Ther 1983; 33: 301–307
  • Poplack D G, Reaman G H, Bleyer W A. Central nervous system (CNS) preventive therapy with high dose methotrexate (HDMTX) in acute lymphoblastic leukemia (ALL): A preliminary report. Proceedings of the 16th Annual Congress of the International Society of Pediatric Oncology. International Society of Pediatric Oncology, Barcelona 1984; 35
  • Bratlid D, Moe P J. Pharmacokinetics of high-dose methotrexate treatment in children. Eur J Clin Pharmacol 1978; 14: 143–147
  • Luyckx M, Cazin J L, Brunet C. Clinical pharmacokinetics of 6-hour infusion of high-dose methotrexate. Preliminary trial of monitoring high infusion doses. Eur J Clin Pharmacol 1985; 28: 457–462
  • Evans W E, Pratt C B, Taylor R H. Pharmacokinetic monitoring of high-dose methotrexate: Early recognition of high-risk patients. Cancer Chemother Pharmacol 1979; 3: 161–166
  • Jacobs S A, Stoller R G, Chabner B A. 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate. J Clin Invest 1976; 57: 534–538
  • Breithaupt H, Kuenzlen E. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following high-dose methotrexate. Cancer Treat Rep 1982; 66: 1733–1741
  • Wang Y-M, Fujimoto T. Clinical pharmacokinetics of methotrexate in children. Clin Pharmacokinet 1984; 9: 335–348
  • Erttman R, Bielack S, Landbeck G. Kinetics of 7-hydroxymethotrexate after high-dose methotrexate therapy. Cancer Chemother Pharmacol 1985; 15: 101–104
  • Djerassi I, Kim J S, Nayak N P. High-dose methotrexate with citrovorum factor rescue: A new approach to cancer chemotherapy. Recent Advances in Cancer Chemotherapy, HJ Taagnon, MJ Staquet. Raven Press, New York 1977; 201–225
  • Erttmann R, Bielack S, Landbeck G. 7-Hydroxymethotrexate and clinical toxicity following high-dose methotrexate therapy. J Cancer Res Clin Oncol 1985; 109: 86–88
  • Slørdal L, Prytz P S, Pettersen I. Methotrexate measurements in plasma. Comparison of EMIT, TDX, and HPLC. Ther Drug Monit, in press
  • Campbell M A, Perrier D G, Dorr R T. Methotrexate: Bioavailability and pharmacokinetics. Cancer Treat Rep 1985; 69: 833–838
  • Newton P A, Blakley R L. 7-Hydroxymethotrexate formation in a human lymphoblastic cell line. Biochem Biophys Res Commun 1984; 122: 1212–1217
  • Høyem-Johansen T, Slørdal L, Høylandskjaer A. The effect of antineoplastic drugs on the pharmacokinetics of antipyrine in the rat. Acta Pharmacol Toxicol 1980; 47: 279–284
  • Slørdal L, Høyem-Johansen T, Aarbakke J. Microsomal metabolism of antipyrine in rats treated with antineoplastic drugs. Pharmacology 1983; 26: 95–99
  • Gaukroger J M, Wilson L. Protection of cells from methotrexate toxicity by 7-hydroxymethotrexate. Br J Cancer 1984; 50: 327–333
  • Fabre G, Goldman I D. Formation of 7-hydroxymethotrexate polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro. Cancer Res 1985; 45: 80–85

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.